- Medewerkers
- 2–10
- Opgericht
- 2025
- Land
- Verenigde Staten
Over Bintel
Bintel develops oncology diagnostic systems designed to identify biologically active disease earlier in the clinical timeline.
Our approach is grounded in translational biology and focuses on liquid biomarkers that reflect tumor activity rather than late structural changes. We prioritize narrow, clinically relevant use cases and build toward validation paths that are compatible with real-world laboratory and pharmaceutical workflows.
Bintel’s work supports clinical research, trial enrichment, and future clinical deployment in defined high-risk populations, with an initial focus on breast and lung oncology.
Trefwoorden
- Cap Table Management
- Equity Tokenization
- Fundraising
- Fundraising Contracts
- Liquid Venture Capital Solutions
Adres
Hoofdkantoor
DelawareVerenigde Staten
Team per functiegebied
Gebaseerd op 4 openbare functieprofielen, stand van 2 september 2026.
- Founder / Owner3
- Finance / Accounting1
Vergelijkbare bedrijven
Bedrijven met een vergelijkbaar profiel.
IntelliBio.Tech
Biotechnology · Amsterdam
2–10 medewerkersBekijk profiel
Biocult
Biotechnology · Uden
11–50 medewerkersBekijk profiel
Digi.Bio
Biotechnology · Amsterdam
2–10 medewerkersBekijk profiel
Tessellate Bio
Biotechnology · Amsterdam
11–50 medewerkersBekijk profiel
inbiome
Biotechnology · Amsterdam
11–50 medewerkersBekijk profiel
Biocult-
Biotechnology · Uden
11–50 medewerkersBekijk profiel